Viewing Study NCT03447132


Ignite Creation Date: 2025-12-24 @ 9:26 PM
Ignite Modification Date: 2026-02-03 @ 5:36 AM
Study NCT ID: NCT03447132
Status: COMPLETED
Last Update Posted: 2023-03-10
First Post: 2018-02-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant
Sponsor: International Cancer Research Group, United Arab Emirates
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasm Female View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None Luminal View
None Neoadjuvant View
None pCR View
None Surgery View